Enjoy complimentary customisation on priority with our Enterprise License!
The Car T-cell therapy market size is forecast to increase by USD 3.03 billion at a CAGR of 16.83% between 2023 and 2028. The market is experiencing significant growth due to the increasing prevalence of hematologic malignancies, such as leukemia and lymphoma, and the trend towards tailoring treatments based on individual patient needs through precision medicine. This approach has led to an increase in the number of product approvals and clinical trials for cell-based therapies. However, the high cost associated with car T-cell therapy remains a challenge for widespread adoption. This analysis report delves into the market growth factors, including the rising awareness of car T-cell therapy and the increasing number of approvals and clinical trials. Despite the high cost, the potential benefits of personalized treatments for hematologic malignancies continue to drive market growth.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.